Kanasi E, Ayilavarapu S, Jones J. The aging population: demographics and the biology of aging. Periodontol 2000. 2016;72(1):13–8.

Article  PubMed  Google Scholar 

Aidoud A, Gana W, Poitau F, Debacq C, Leroy V, Nkodo JA, et al. High prevalence of geriatric conditions among older adults with cardiovascular disease. J Am Heart Assoc. 2023;12(2): e026850.

Article  PubMed  PubMed Central  Google Scholar 

Sinclair AJ, Abdelhafiz AH. Multimorbidity, frailty and diabetes in older people-identifying interrelationships and outcomes. J Pers Med. 2022;12(11):1911.

Article  PubMed  PubMed Central  Google Scholar 

Zazzara MB, Palmer K, Vetrano DL, Carfì A, Onder G. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med. 2021;12(3):463–73.

Article  PubMed  PubMed Central  Google Scholar 

Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96.

Article  PubMed  Google Scholar 

Hsu HF, Chen KM, Belcastro F, Chen YF. Polypharmacy and pattern of medication use in community-dwelling older adults: a systematic review. J Clin Nurs. 2021;30(7–8):918–28.

Article  PubMed  Google Scholar 

Garcia-Caballos M, Ramos-Diaz F, Jimenez-Moleon JJ, Bueno-Cavanillas A. Drug-related problems in older people after hospital discharge and interventions to reduce them. Age Ageing. 2010;39(4):430–8.

Article  PubMed  Google Scholar 

Plácido AI, Herdeiro MT, Morgado M, Figueiras A, Roque F. Drug-related problems in home-dwelling older adults: a systematic review. Clin Ther. 2020;42(4):559-72.e14.

Article  PubMed  Google Scholar 

Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.

Article  PubMed  Google Scholar 

Chiatti C, Bustacchini S, Furneri G, Mantovani L, Cristiani M, Misuraca C, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people. Drug Saf. 2012;35(1):73–87.

Article  PubMed  Google Scholar 

Alqenae FA, Steinke D, Keers RN. Prevalence and nature of medication errors and medication-related harm following discharge from hospital to community settings: a systematic review. Drug Saf. 2020;43(6):517–37.

Article  PubMed  PubMed Central  Google Scholar 

Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR. Hospitalization in older patients due to adverse drug reactions: the need for a prediction tool. Clin Interv Aging. 2016;11:497–505.

Article  PubMed  PubMed Central  Google Scholar 

Salvi F, Marchetti A, D’Angelo F, Boemi M, Lattanzio F, Cherubini A. Adverse drug events as a cause of hospitalization in older adults. Drug Saf. 2012;35(1):29–45.

Article  PubMed  Google Scholar 

Angamo MT, Chalmers L, Curtain CM, Bereznicki LRE. Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39(9):847–57.

Article  CAS  PubMed  Google Scholar 

El Morabet N, Uitvlugt EB, Bemt BJF, Bemt P, Janssen MJA, Karapinar-Carkit F. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66(3):602–8.

Article  PubMed  Google Scholar 

Linkens AEMJH, Milosevic V, van der Kuy PHM, Damen-Hendriks VH, Mestres Gonzalvo C, Hurkens KPGM. Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm. 2020;42(5):1243–51.

Ruiz-Ramos J, Juanes-Borrego A, Puig-Campany M, Blazquez-Andión M, López-Vinardell L, Gilabert-Perramon A, et al. Cost-effectiveness analysis of implementing a secondary prevention programme in those patients who visited an emergency department for drug-related problems. Int J Pharm Pract. 2022;30(5):434–40.

Article  PubMed  Google Scholar 

Wright EA, Graham JH, Maeng D, Tusing L, Zaleski L, Martin R, et al. Reductions in 30-day readmission, mortality, and costs with inpatient-to-community pharmacist follow-up. J Am Pharm Assoc. 2019;59(2):178–86.

Article  Google Scholar 

Pharmaceutical Care Network Europe. Classification for drug related problems. The PCNE classification V 6.2. https://www.pcne.org/upload/files/11_PCNE_classification_V6-2.pdf. Accessed 27 May 2023.

Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795–801.

Article  PubMed  Google Scholar 

Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Inern Med. 2008;168(17):1890–6.

Google Scholar 

National Coordinating Council for Medication Error Reporting and Prevention. http://www.nccmerp.org/sites/default/files/nccmerp_fact_sheet_2015-02-v91.pdf. Accessed 27 May 2023.

Hauviller L, Eyvrard F, Garnault V, Rousseau V, Molinier L, Montastruc JL, et al. Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years. Eur J Clin Pharmacol. 2016;72(5):631–9.

Article  CAS  PubMed  Google Scholar 

Kempen TGH, Hedman AN, Hadziosmanovic N, Lindner KJ, Melhus H, Nielsen EI, et al. Risk factors for and preventability of drug-related hospital revisits in older patients: a post-hoc analysis of a randomized clinical trial. Br J Clin Pharmacol. 2023;89(5):1575–87.

Article  PubMed  Google Scholar 

Ekerstad N, Bylin K, Karlson BW. Early rehospitalizations of frail elderly patients: the role of medications: a clinical, prospective, observational trial. Drug Healthc Patient Saf. 2017;9:77–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parekh N, Ali K, Stevenson JM, Davies JG, Schiff R, Van der Cammen T, et al. Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK: incidence and cost of medication harm in older adults. Br J Clin Pharmacol. 2018;84(8):1789–97.

Article  PubMed  PubMed Central  Google Scholar 

Hallas J, Harvald B, Gram LF, Grodum E, Brøsen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.

Article  CAS  PubMed  Google Scholar 

Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003;12(4):280–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olivier P, Caron J, Haramburu F, Imbs J-L, Jonville-Béra A-P, Lagier G, et al. Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale. Therapie. 2005;60(1):39–45.

Article  PubMed  Google Scholar 

Kimmick GG, Fleming R, Muss HB, Balducci L. Cancer chemotherapy in older adults: a tolerability perspective. Drugs Aging. 1997;10(1):34–49.

Article  CAS  PubMed  Google Scholar 

García-Pérez L, Linertová R, Lorenzo-Riera A, Vázquez-Díaz JR, Duque-González B, Sarría-Santamera A. Risk factors for hospital readmissions in elderly patients: a systematic review. QJM. 2011;104(8):639–51.

Article  PubMed  Google Scholar 

Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015;31(3):184–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Australian Commission on Safety and Quality in Health Care. APINCHS classification of high risk medicines. https://www.safetyandquality.gov.au/our-work/medication-safety/high-risk-medicines/apinchs-classification-high-risk-medicines. Accessed 27 May 2023.

Wojt IR, Cairns R, Gillooly I, Patanwala AE, Tan ECK. Clinical factors associated with increased length of stay and readmission in patients with medication-related hospital admissions: a retrospective study. Res Soc Admin Pharm. 2022;18(7):3184–90.

Article  Google Scholar 

Ćurković M, Dodig-Ćurković K, Erić AP, Kralik K, Pivac N. Psychotropic medications in older adults: a review. Psychiatr Danub. 2016;28(1):13–24.

PubMed  Google Scholar 

Parks ALMD, Fang MCMDMPH. Anticoagulation in older adults with multimorbidity. Clin Geriatr Med. 2016;32(2):331–46.

Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12(3):443–52.

Article  PubMed  PubMed Central  Google Scholar 

NSW Therapeutic Advisory Group Inc. Deprescribing tools. https://www.nswtag.org.au/deprescribing-tools/. Accessed 27 May 2023.

Kurczewska-Michalak M, Lewek P, Jankowska-Polańska B, Giardini A, Granata N, Maffoni M, et al. Polypharmacy management in the older adults: a scoping review of available interventions. Front Pharmacol. 2021;12: 734045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verma A, Saha S, Jarl J, Conlon E, McGuinness B, Trépel D. An overview of systematic reviews and meta-analyses on the effect of medication interventions targeting polypharmacy for frail older adults. J Clin Med. 2023;12(4):1379.

Article  PubMed  PubMed Central  Google Scholar 

Liebzeit D, Rutkowski R, Arbaje AI, Fields B, Werner NE. A scoping review of interventions for older adults transitioning from hospital to home. J Am Geriatr Soc. 2021;69(10):2950–62.

Article  PubMed  PubMed Central  Google Scholar 

Ozavci G, Bucknall T, Woodward-Kron R, Hughes C, Jorm C, Joseph K, et al. A systematic review of older patients’ experiences and perceptions of communication about managing medication across transitions of care. Res Soc Admin Pharma. 2021;17(2):273–91.

Article  Google Scholar